{"id":"NCT02467842","sponsor":"SK Chemicals Co., Ltd.","briefTitle":"Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects","officialTitle":"A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess the Immunogenicity and Safety of Quadrivalent Inactivated Cell Culture-derived Influenza Vaccine in Adults and Elderly Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10","primaryCompletion":"2014-12","completion":"2015-05","firstPosted":"2015-06-10","resultsPosted":"2020-05-08","lastUpdate":"2020-05-08"},"enrollment":1503,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"NBP607-QIV","otherNames":[]},{"type":"BIOLOGICAL","name":"NBP607-Y","otherNames":[]},{"type":"BIOLOGICAL","name":"NBP607-V","otherNames":[]}],"arms":[{"label":"NBP607-QIV","type":"EXPERIMENTAL"},{"label":"NBP607-Y","type":"ACTIVE_COMPARATOR"},{"label":"NBP607-V","type":"ACTIVE_COMPARATOR"}],"summary":"All participants received a single dose of their assigned vaccine on Day 0. They were followed up for immunogenicity and safety through Day 21 post-vaccination. Serious adverse events were collected for 6 months post-vaccination.","primaryOutcome":{"measure":"Geometric Mean HI Titers (GMTs) After Vaccination in All Subjects","timeFrame":"At Day 21 post vaccination.","effectByArm":[{"arm":"NBP607-QIV","deltaMin":329.76,"sd":null},{"arm":"NBP607-Y","deltaMin":334.98,"sd":null},{"arm":"NBP607-V","deltaMin":334.98,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":null},{"comp":"OG000 vs OG001 vs OG002","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null}]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28406746"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":752},"commonTop":["Tenderness","Pain","Myalgia","Fatigue/Malaise","Headache"]}}